We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The Charity Commission is seeking your views on the charitable status of complementary and alternative medicines.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
The process for the simultaneous review of veterinary medicine submissions by New Zealand’s Ministry for Primary Industries (MPI) and the UK's Veterinary Medicines Directorate.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
The process for the simultaneous review of veterinary medicine submissions by Switzerland’s Swissmedic and the UK's Veterinary Medicines Directorate.
Guidance about working in collaboration with other charities.
The process for the simultaneous review of veterinary drug submissions by Health Canada’s Veterinary Drugs Directorate and the UK's Veterinary Medicines Directorate.
How to apply for simultaneous review of veterinary medicine submissions to the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the VMD.
How to use a contextual inquiry when developing your digital health product.
Use these general provisions to help you determine the origin of your products.
The authors test for the existence of complementarities between internal R&D and external innovation activities
How to use a quasi-experimental study to evaluate your digital health product.
The Lambert toolkit is for universities and companies that wish to undertake collaborative research projects with each other.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
How to use a crossover randomised controlled trial to evaluate your digital health product.
A summary of what delivering better integrated care means and how Monitor is supporting the sector.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).